Identification of FOS as a Candidate Risk Gene for Liver Cancer by Integrated Bioinformatic Analysis

Table 3

Clinical characteristics of HCC patients.

Clinical and pathologic indexes		High FOS	Low FOS
		N = 264	N = 118
Age, y	>50	172	73	0.56
	≤50	92	45
Gender	Female	29	16	0.49
	Male	235	102
HBsAg	Negative	55	36	0.05
	Positive	209	82
With liver cirrhosis	No	6	1	0.44
	Yes	258	117
Portal lymph node	Negative	255	112	0.41
	Positive	9	6
AFP (ng/ml)	≤400	99	59	0.02
	>400	165	59
MVI	Negative	200	83	0.31
	Positive	64	35
Tumor number	Multiple	67	27	0.70
	Single	197	91
Tumor size, cm	>5	146	69	0.58
	≤5	118	49
PVTT	Negative	165	57	0.01
	Positive	99	61
GGT (U/L)	>54	185	79	0.55
	≤54	79	39
Tumor encapsulation	Complete	132	57	0.83
	None	132	61
Edmondson stage	I-II	193	76	0.09
	II-IV	71	42

Note. Categorical data were analyzed by the chi-squared test. .